Analyst Matthew DeYoe of Bank of America Securities reiterated a Hold rating on Sherwin-Williams Company, retaining the price target of $370.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Matthew DeYoe has given his Hold rating due to a combination of factors tied to Sherwin-Williams’ current performance and future outlook. The company modestly beat fourth-quarter earnings expectations on the strength of improved margins and disciplined cost control, yet full-year profit growth was minimal, indicating limited underlying momentum. Looking ahead to 2026, management’s earnings guidance appears surprisingly restrained given anticipated price gains in Performance Coatings, favorable currency movements, and expected organic growth across divisions. The low end of the guidance range seems difficult to justify without assuming a more significant downturn in demand, while the high end still implies only modest earnings growth.
DeYoe also notes that several headwinds and uncertainties constrain upside potential in the near term. Integration costs from the Suvinil acquisition, higher raw material and healthcare expenses, and increased interest costs all weigh on the earnings trajectory, with the acquisition not expected to add much to operating profit initially. In addition, management will not update full-year guidance until at least the second quarter, leaving limited near-term catalysts to re-rate the stock. With the shares already trading close to his unchanged price objective of $370 and a muted outlook for housing, DeYoe sees little scope for valuation multiple expansion, leading him to maintain a Neutral (Hold) stance on Sherwin-Williams.
DeYoe covers the Basic Materials sector, focusing on stocks such as RPM International, Sherwin-Williams Company, and Westlake Corporation. According to TipRanks, DeYoe has an average return of 8.3% and a 65.22% success rate on recommended stocks.

